Report Cover

Global Point of Care Infectious Disease Market 2021 by Company, Regions, Type and Application, Forecast to 2026


The Point of Care Infectious Disease market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Point of Care Infectious Disease size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global Point of Care Infectious Disease market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Point of Care Infectious Disease market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    HIV POC
    Clostridium difficile POC
    HBV POC
    Pneumonia or Streptococcus associated infections
    Respiratory syncytial virus (RSV) POC
    HPV POC
    Influenza/Flu POC
    HCV POC
    MRSA POC
    TB and drug-resistant TB POC

Market segment by Application, can be divided into
    Hospitals
    Clinics
    Home
    Assisted Living Healthcare Facilities
    Laboratories
    Others

Market segment by players, this report covers
    Siemens Healthineers
    Trivitron Healthcare
    F. Hoffmann-La Roche Ltd
    Abbott
    Quest Diagnostics, Inc
    BD & Company
    Chembio Diagnostics Inc
    Trinity Biotech
    Cardinal Health
    Bio-Rad Labs Inc.
    bioMA(C)rieux SA
    Thermo Fisher Scientific Inc
    Sight Diagnostics Ltd.
    Gene POC
    Ortho-Clinical Diagnostics
    OJ-Bio Ltd.

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
    1.1 Product Overview and Scope of Point of Care Infectious Disease
    1.2 Classification of Point of Care Infectious Disease by Type
        1.2.1 Overview: Global Point of Care Infectious Disease Market Size by Type: 2020 Versus 2021 Versus 2026
        1.2.2 Global Point of Care Infectious Disease Revenue Market Share by Type in 2020
        1.2.3 HIV POC
        1.2.4 Clostridium difficile POC
        1.2.5 HBV POC
        1.2.6 Pneumonia or Streptococcus associated infections
        1.2.7 Respiratory syncytial virus (RSV) POC
        1.2.8 HPV POC
        1.2.9 Influenza/Flu POC
        1.2.10 HCV POC
        1.2.11 MRSA POC
        1.2.12 TB and drug-resistant TB POC
    1.3 Global Point of Care Infectious Disease Market by Application
        1.3.1 Overview: Global Point of Care Infectious Disease Market Size by Application: 2020 Versus 2021 Versus 2026
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Home
        1.3.5 Assisted Living Healthcare Facilities
        1.3.6 Laboratories
        1.3.7 Others
    1.4 Global Point of Care Infectious Disease Market Size & Forecast
    1.5 Global Point of Care Infectious Disease Market Size and Forecast by Region
        1.5.1 Global Point of Care Infectious Disease Market Size by Region: 2016 VS 2021 VS 2026
        1.5.2 Global Point of Care Infectious Disease Market Size by Region, (2016-2021)
        1.5.3 North America Point of Care Infectious Disease Market Size and Prospect (2016-2026)
        1.5.4 Europe Point of Care Infectious Disease Market Size and Prospect (2016-2026)
        1.5.5 Asia-Pacific Point of Care Infectious Disease Market Size and Prospect (2016-2026)
        1.5.6 South America Point of Care Infectious Disease Market Size and Prospect (2016-2026)
        1.5.7 Middle East and Africa Point of Care Infectious Disease Market Size and Prospect (2016-2026)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Point of Care Infectious Disease Market Drivers
        1.6.2 Point of Care Infectious Disease Market Restraints
        1.6.3 Point of Care Infectious Disease Trends Analysis
2 Company Profiles
    2.1 Siemens Healthineers
        2.1.1 Siemens Healthineers Details
        2.1.2 Siemens Healthineers Major Business
        2.1.3 Siemens Healthineers Point of Care Infectious Disease Product and Solutions
        2.1.4 Siemens Healthineers Point of Care Infectious Disease Revenue, Gross Margin and Market Share (2019-2021)
        2.1.5 Siemens Healthineers Recent Developments and Future Plans
    2.2 Trivitron Healthcare
        2.2.1 Trivitron Healthcare Details
        2.2.2 Trivitron Healthcare Major Business
        2.2.3 Trivitron Healthcare Point of Care Infectious Disease Product and Solutions
        2.2.4 Trivitron Healthcare Point of Care Infectious Disease Revenue, Gross Margin and Market Share (2019-2021)
        2.2.5 Trivitron Healthcare Recent Developments and Future Plans
    2.3 F. Hoffmann-La Roche Ltd
        2.3.1 F. Hoffmann-La Roche Ltd Details
        2.3.2 F. Hoffmann-La Roche Ltd Major Business
        2.3.3 F. Hoffmann-La Roche Ltd Point of Care Infectious Disease Product and Solutions
        2.3.4 F. Hoffmann-La Roche Ltd Point of Care Infectious Disease Revenue, Gross Margin and Market Share (2019-2021)
        2.3.5 F. Hoffmann-La Roche Ltd Recent Developments and Future Plans
    2.4 Abbott
        2.4.1 Abbott Details
        2.4.2 Abbott Major Business
        2.4.3 Abbott Point of Care Infectious Disease Product and Solutions
        2.4.4 Abbott Point of Care Infectious Disease Revenue, Gross Margin and Market Share (2019-2021)
        2.4.5 Abbott Recent Developments and Future Plans
    2.5 Quest Diagnostics, Inc
        2.5.1 Quest Diagnostics, Inc Details
        2.5.2 Quest Diagnostics, Inc Major Business
        2.5.3 Quest Diagnostics, Inc Point of Care Infectious Disease Product and Solutions
        2.5.4 Quest Diagnostics, Inc Point of Care Infectious Disease Revenue, Gross Margin and Market Share (2019-2021)
        2.5.5 Quest Diagnostics, Inc Recent Developments and Future Plans
    2.6 BD & Company
        2.6.1 BD & Company Details
        2.6.2 BD & Company Major Business
        2.6.3 BD & Company Point of Care Infectious Disease Product and Solutions
        2.6.4 BD & Company Point of Care Infectious Disease Revenue, Gross Margin and Market Share (2019-2021)
        2.6.5 BD & Company Recent Developments and Future Plans
    2.7 Chembio Diagnostics Inc
        2.7.1 Chembio Diagnostics Inc Details
        2.7.2 Chembio Diagnostics Inc Major Business
        2.7.3 Chembio Diagnostics Inc Point of Care Infectious Disease Product and Solutions
        2.7.4 Chembio Diagnostics Inc Point of Care Infectious Disease Revenue, Gross Margin and Market Share (2019-2021)
        2.7.5 Chembio Diagnostics Inc Recent Developments and Future Plans
    2.8 Trinity Biotech
        2.8.1 Trinity Biotech Details
        2.8.2 Trinity Biotech Major Business
        2.8.3 Trinity Biotech Point of Care Infectious Disease Product and Solutions
        2.8.4 Trinity Biotech Point of Care Infectious Disease Revenue, Gross Margin and Market Share (2019-2021)
        2.8.5 Trinity Biotech Recent Developments and Future Plans
    2.9 Cardinal Health
        2.9.1 Cardinal Health Details
        2.9.2 Cardinal Health Major Business
        2.9.3 Cardinal Health Point of Care Infectious Disease Product and Solutions
        2.9.4 Cardinal Health Point of Care Infectious Disease Revenue, Gross Margin and Market Share (2019-2021)
        2.9.5 Cardinal Health Recent Developments and Future Plans
    2.10 Bio-Rad Labs Inc. 
        2.10.1 Bio-Rad Labs Inc. Details
        2.10.2 Bio-Rad Labs Inc. Major Business
        2.10.3 Bio-Rad Labs Inc. Point of Care Infectious Disease Product and Solutions
        2.10.4 Bio-Rad Labs Inc. Point of Care Infectious Disease Revenue, Gross Margin and Market Share (2019-2021)
        2.10.5 Bio-Rad Labs Inc. Recent Developments and Future Plans
    2.11 bioMA(C)rieux SA
        2.11.1 bioMA(C)rieux SA Details
        2.11.2 bioMA(C)rieux SA Major Business
        2.11.3 bioMA(C)rieux SA Point of Care Infectious Disease Product and Solutions
        2.11.4 bioMA(C)rieux SA Point of Care Infectious Disease Revenue, Gross Margin and Market Share (2019-2021)
        2.11.5 bioMA(C)rieux SA Recent Developments and Future Plans
    2.12 Thermo Fisher Scientific Inc
        2.12.1 Thermo Fisher Scientific Inc Details
        2.12.2 Thermo Fisher Scientific Inc Major Business
        2.12.3 Thermo Fisher Scientific Inc Point of Care Infectious Disease Product and Solutions
        2.12.4 Thermo Fisher Scientific Inc Point of Care Infectious Disease Revenue, Gross Margin and Market Share (2019-2021)
        2.12.5 Thermo Fisher Scientific Inc Recent Developments and Future Plans
    2.13 Sight Diagnostics Ltd.
        2.13.1 Sight Diagnostics Ltd. Details
        2.13.2 Sight Diagnostics Ltd. Major Business
        2.13.3 Sight Diagnostics Ltd. Point of Care Infectious Disease Product and Solutions
        2.13.4 Sight Diagnostics Ltd. Point of Care Infectious Disease Revenue, Gross Margin and Market Share (2019-2021)
        2.13.5 Sight Diagnostics Ltd. Recent Developments and Future Plans
    2.14 Gene POC
        2.14.1 Gene POC Details
        2.14.2 Gene POC Major Business
        2.14.3 Gene POC Point of Care Infectious Disease Product and Solutions
        2.14.4 Gene POC Point of Care Infectious Disease Revenue, Gross Margin and Market Share (2019-2021)
        2.14.5 Gene POC Recent Developments and Future Plans
    2.15 Ortho-Clinical Diagnostics
        2.15.1 Ortho-Clinical Diagnostics Details
        2.15.2 Ortho-Clinical Diagnostics Major Business
        2.15.3 Ortho-Clinical Diagnostics Point of Care Infectious Disease Product and Solutions
        2.15.4 Ortho-Clinical Diagnostics Point of Care Infectious Disease Revenue, Gross Margin and Market Share (2019-2021)
        2.15.5 Ortho-Clinical Diagnostics Recent Developments and Future Plans
    2.16 OJ-Bio Ltd.
        2.16.1 OJ-Bio Ltd. Details
        2.16.2 OJ-Bio Ltd. Major Business
        2.16.3 OJ-Bio Ltd. Point of Care Infectious Disease Product and Solutions
        2.16.4 OJ-Bio Ltd. Point of Care Infectious Disease Revenue, Gross Margin and Market Share (2019-2021)
        2.16.5 OJ-Bio Ltd. Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 Global Point of Care Infectious Disease Revenue and Share by Players (2019-2021)
    3.2 Market Concentration Rate
        3.2.1 Top 5 Point of Care Infectious Disease Players Market Share
        3.2.2 Top 10 Point of Care Infectious Disease Players Market Share
        3.2.3 Market Competition Trend
    3.3 Point of Care Infectious Disease Players Head Office, Products and Services Provided
    3.4 Mergers & Acquisitions
    3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
    4.1 Global Point of Care Infectious Disease Revenue and Market Share by Type (2016-2021)
    4.2 Global Point of Care Infectious Disease Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
    5.1 Global Point of Care Infectious Disease Revenue Market Share by Application (2016-2021)
    5.2 Point of Care Infectious Disease Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
    6.1 North America Point of Care Infectious Disease Revenue by Type (2016-2026)
    6.2 North America Point of Care Infectious Disease Revenue by Application (2016-2026)
    6.3 North America Point of Care Infectious Disease Market Size by Country
        6.3.1 North America Point of Care Infectious Disease Revenue by Country (2016-2026)
        6.3.2 United States Point of Care Infectious Disease Market Size and Forecast (2016-2026)
        6.3.3 Canada Point of Care Infectious Disease Market Size and Forecast (2016-2026)
        6.3.4 Mexico Point of Care Infectious Disease Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
    7.1 Europe Point of Care Infectious Disease Revenue by Type (2016-2026)
    7.2 Europe Point of Care Infectious Disease Revenue by Application (2016-2026)
    7.3 Europe Point of Care Infectious Disease Market Size by Country
        7.3.1 Europe Point of Care Infectious Disease Revenue by Country (2016-2026)
        7.3.2 Germany Point of Care Infectious Disease Market Size and Forecast (2016-2026)
        7.3.3 France Point of Care Infectious Disease Market Size and Forecast (2016-2026)
        7.3.4 United Kingdom Point of Care Infectious Disease Market Size and Forecast (2016-2026)
        7.3.5 Russia Point of Care Infectious Disease Market Size and Forecast (2016-2026)
        7.3.6 Italy Point of Care Infectious Disease Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Point of Care Infectious Disease Revenue by Type (2016-2026)
    8.2 Asia-Pacific Point of Care Infectious Disease Revenue by Application (2016-2026)
    8.3 Asia-Pacific Point of Care Infectious Disease Market Size by Region
        8.3.1 Asia-Pacific Point of Care Infectious Disease Revenue by Region (2016-2026)
        8.3.2 China Point of Care Infectious Disease Market Size and Forecast (2016-2026)
        8.3.3 Japan Point of Care Infectious Disease Market Size and Forecast (2016-2026)
        8.3.4 South Korea Point of Care Infectious Disease Market Size and Forecast (2016-2026)
        8.3.5 India Point of Care Infectious Disease Market Size and Forecast (2016-2026)
        8.3.6 Southeast Asia Point of Care Infectious Disease Market Size and Forecast (2016-2026)
        8.3.7 Australia Point of Care Infectious Disease Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
    9.1 South America Point of Care Infectious Disease Revenue by Type (2016-2026)
    9.2 South America Point of Care Infectious Disease Revenue by Application (2016-2026)
    9.3 South America Point of Care Infectious Disease Market Size by Country
        9.3.1 South America Point of Care Infectious Disease Revenue by Country (2016-2026)
        9.3.2 Brazil Point of Care Infectious Disease Market Size and Forecast (2016-2026)
        9.3.3 Argentina Point of Care Infectious Disease Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Point of Care Infectious Disease Revenue by Type (2016-2026)
    10.2 Middle East & Africa Point of Care Infectious Disease Revenue by Application (2016-2026)
    10.3 Middle East & Africa Point of Care Infectious Disease Market Size by Country
        10.3.1 Middle East & Africa Point of Care Infectious Disease Revenue by Country (2016-2026)
        10.3.2 Turkey Point of Care Infectious Disease Market Size and Forecast (2016-2026)
        10.3.3 Saudi Arabia Point of Care Infectious Disease Market Size and Forecast (2016-2026)
        10.3.4 UAE Point of Care Infectious Disease Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

List of Tables Table 1. Global Point of Care Infectious Disease Revenue by Type, (USD Million), 2020 VS 2021 VS 2026 Table 2. Global Point of Care Infectious Disease Revenue by Application, (USD Million), 2020 VS 2021 VS 2026 Table 3. Global Market Point of Care Infectious Disease Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026) Table 4. Global Point of Care Infectious Disease Revenue (USD Million) by Region (2016-2021) Table 5. Global Point of Care Infectious Disease Revenue Market Share by Region (2021-2026) Table 6. Siemens Healthineers Corporate Information, Head Office, and Major Competitors Table 7. Siemens Healthineers Major Business Table 8. Siemens Healthineers Point of Care Infectious Disease Product and Solutions Table 9. Siemens Healthineers Point of Care Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 10. Trivitron Healthcare Corporate Information, Head Office, and Major Competitors Table 11. Trivitron Healthcare Major Business Table 12. Trivitron Healthcare Point of Care Infectious Disease Product and Solutions Table 13. Trivitron Healthcare Point of Care Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 14. F. Hoffmann-La Roche Ltd Corporate Information, Head Office, and Major Competitors Table 15. F. Hoffmann-La Roche Ltd Major Business Table 16. F. Hoffmann-La Roche Ltd Point of Care Infectious Disease Product and Solutions Table 17. F. Hoffmann-La Roche Ltd Point of Care Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 18. Abbott Corporate Information, Head Office, and Major Competitors Table 19. Abbott Major Business Table 20. Abbott Point of Care Infectious Disease Product and Solutions Table 21. Abbott Point of Care Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 22. Quest Diagnostics, Inc Corporate Information, Head Office, and Major Competitors Table 23. Quest Diagnostics, Inc Major Business Table 24. Quest Diagnostics, Inc Point of Care Infectious Disease Product and Solutions Table 25. Quest Diagnostics, Inc Point of Care Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 26. BD & Company Corporate Information, Head Office, and Major Competitors Table 27. BD & Company Major Business Table 28. BD & Company Point of Care Infectious Disease Product and Solutions Table 29. BD & Company Point of Care Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 30. Chembio Diagnostics Inc Corporate Information, Head Office, and Major Competitors Table 31. Chembio Diagnostics Inc Major Business Table 32. Chembio Diagnostics Inc Point of Care Infectious Disease Product and Solutions Table 33. Chembio Diagnostics Inc Point of Care Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 34. Trinity Biotech Corporate Information, Head Office, and Major Competitors Table 35. Trinity Biotech Major Business Table 36. Trinity Biotech Point of Care Infectious Disease Product and Solutions Table 37. Trinity Biotech Point of Care Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 38. Cardinal Health Corporate Information, Head Office, and Major Competitors Table 39. Cardinal Health Major Business Table 40. Cardinal Health Point of Care Infectious Disease Product and Solutions Table 41. Cardinal Health Point of Care Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 42. Bio-Rad Labs Inc. Corporate Information, Head Office, and Major Competitors Table 43. Bio-Rad Labs Inc. Major Business Table 44. Bio-Rad Labs Inc. Point of Care Infectious Disease Product and Solutions Table 45. Bio-Rad Labs Inc. Point of Care Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 46. bioMA(C)rieux SA Corporate Information, Head Office, and Major Competitors Table 47. bioMA(C)rieux SA Major Business Table 48. bioMA(C)rieux SA Point of Care Infectious Disease Product and Solutions Table 49. bioMA(C)rieux SA Point of Care Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 50. Thermo Fisher Scientific Inc Corporate Information, Head Office, and Major Competitors Table 51. Thermo Fisher Scientific Inc Major Business Table 52. Thermo Fisher Scientific Inc Point of Care Infectious Disease Product and Solutions Table 53. Thermo Fisher Scientific Inc Point of Care Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 54. Sight Diagnostics Ltd. Corporate Information, Head Office, and Major Competitors Table 55. Sight Diagnostics Ltd. Major Business Table 56. Sight Diagnostics Ltd. Point of Care Infectious Disease Product and Solutions Table 57. Sight Diagnostics Ltd. Point of Care Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 58. Gene POC Corporate Information, Head Office, and Major Competitors Table 59. Gene POC Major Business Table 60. Gene POC Point of Care Infectious Disease Product and Solutions Table 61. Gene POC Point of Care Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 62. Ortho-Clinical Diagnostics Corporate Information, Head Office, and Major Competitors Table 63. Ortho-Clinical Diagnostics Major Business Table 64. Ortho-Clinical Diagnostics Point of Care Infectious Disease Product and Solutions Table 65. Ortho-Clinical Diagnostics Point of Care Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 66. OJ-Bio Ltd. Corporate Information, Head Office, and Major Competitors Table 67. OJ-Bio Ltd. Major Business Table 68. OJ-Bio Ltd. Point of Care Infectious Disease Product and Solutions Table 69. OJ-Bio Ltd. Point of Care Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 70. Global Point of Care Infectious Disease Revenue (USD Million) by Players (2019-2021) Table 71. Global Point of Care Infectious Disease Revenue Share by Players (2019-2021) Table 72. Breakdown of Point of Care Infectious Disease by Company Type (Tier 1, Tier 2 and Tier 3) Table 73. Point of Care Infectious Disease Players Head Office, Products and Services Provided Table 74. Point of Care Infectious Disease Mergers & Acquisitions in the Past Five Years Table 75. Point of Care Infectious Disease New Entrants and Expansion Plans Table 76. Global Point of Care Infectious Disease Revenue (USD Million) by Type (2016-2021) Table 77. Global Point of Care Infectious Disease Revenue Share by Type (2016-2021) Table 78. Global Point of Care Infectious Disease Revenue Forecast by Type (2021-2026) Table 79. Global Point of Care Infectious Disease Revenue by Application (2016-2021) Table 80. Global Point of Care Infectious Disease Revenue Forecast by Application (2021-2026) Table 81. North America Point of Care Infectious Disease Revenue by Type (2016-2021) & (USD Million) Table 82. North America Point of Care Infectious Disease Revenue by Type (2021-2026) & (USD Million) Table 83. North America Point of Care Infectious Disease Revenue by Application (2016-2021) & (USD Million) Table 84. North America Point of Care Infectious Disease Revenue by Application (2021-2026) & (USD Million) Table 85. North America Point of Care Infectious Disease Revenue by Country (2016-2021) & (USD Million) Table 86. North America Point of Care Infectious Disease Revenue by Country (2021-2026) & (USD Million) Table 87. Europe Point of Care Infectious Disease Revenue by Type (2016-2021) & (USD Million) Table 88. Europe Point of Care Infectious Disease Revenue by Type (2021-2026) & (USD Million) Table 89. Europe Point of Care Infectious Disease Revenue by Application (2016-2021) & (USD Million) Table 90. Europe Point of Care Infectious Disease Revenue by Application (2021-2026) & (USD Million) Table 91. Europe Point of Care Infectious Disease Revenue by Country (2016-2021) & (USD Million) Table 92. Europe Point of Care Infectious Disease Revenue by Country (2021-2026) & (USD Million) Table 93. Asia-Pacific Point of Care Infectious Disease Revenue by Type (2016-2021) & (USD Million) Table 94. Asia-Pacific Point of Care Infectious Disease Revenue by Type (2021-2026) & (USD Million) Table 95. Asia-Pacific Point of Care Infectious Disease Revenue by Application (2016-2021) & (USD Million) Table 96. Asia-Pacific Point of Care Infectious Disease Revenue by Application (2021-2026) & (USD Million) Table 97. Asia-Pacific Point of Care Infectious Disease Revenue by Region (2016-2021) & (USD Million) Table 98. Asia-Pacific Point of Care Infectious Disease Revenue by Region (2021-2026) & (USD Million) Table 99. South America Point of Care Infectious Disease Revenue by Type (2016-2021) & (USD Million) Table 100. South America Point of Care Infectious Disease Revenue by Type (2021-2026) & (USD Million) Table 101. South America Point of Care Infectious Disease Revenue by Application (2016-2021) & (USD Million) Table 102. South America Point of Care Infectious Disease Revenue by Application (2021-2026) & (USD Million) Table 103. South America Point of Care Infectious Disease Revenue by Country (2016-2021) & (USD Million) Table 104. South America Point of Care Infectious Disease Revenue by Country (2021-2026) & (USD Million) Table 105. Middle East & Africa Point of Care Infectious Disease Revenue by Type (2016-2021) & (USD Million) Table 106. Middle East & Africa Point of Care Infectious Disease Revenue by Type (2021-2026) & (USD Million) Table 107. Middle East & Africa Point of Care Infectious Disease Revenue by Application (2016-2021) & (USD Million) Table 108. Middle East & Africa Point of Care Infectious Disease Revenue by Application (2021-2026) & (USD Million) Table 109. Middle East & Africa Point of Care Infectious Disease Revenue by Country (2016-2021) & (USD Million) Table 110. Middle East & Africa Point of Care Infectious Disease Revenue by Country (2021-2026) & (USD Million) List of Figures Figure 1. Point of Care Infectious Disease Picture Figure 2. Global Point of Care Infectious Disease Revenue Market Share by Type in 2020 Figure 3. HIV POC Figure 4. Clostridium difficile POC Figure 5. HBV POC Figure 6. Pneumonia or Streptococcus associated infections Figure 7. Respiratory syncytial virus (RSV) POC Figure 8. HPV POC Figure 9. Influenza/Flu POC Figure 10. HCV POC Figure 11. MRSA POC Figure 12. TB and drug-resistant TB POC Figure 13. Point of Care Infectious Disease Revenue Market Share by Application in 2020 Figure 14. Hospitals Picture Figure 15. Clinics Picture Figure 16. Home Picture Figure 17. Assisted Living Healthcare Facilities Picture Figure 18. Laboratories Picture Figure 19. Others Picture Figure 20. Global Point of Care Infectious Disease Revenue, (USD Million): 2020 VS 2021 VS 2026 Figure 21. Global Point of Care Infectious Disease Revenue and Forecast (2016-2026) & (USD Million) Figure 22. Global Point of Care Infectious Disease Revenue Market Share by Region (2016-2026) Figure 23. Global Point of Care Infectious Disease Revenue Market Share by Region in 2020 Figure 24. North America Point of Care Infectious Disease Revenue (USD Million) and Growth Rate (2016-2026) Figure 25. Europe Point of Care Infectious Disease Revenue (USD Million) and Growth Rate (2016-2026) Figure 26. Asia-Pacific Point of Care Infectious Disease Revenue (USD Million) and Growth Rate (2016-2026) Figure 27. South America Point of Care Infectious Disease Revenue (USD Million) and Growth Rate (2016-2026) Figure 28. Point of Care Infectious Disease Market Drivers Figure 29. Point of Care Infectious Disease Market Restraints Figure 30. Point of Care Infectious Disease Market Trends Figure 31. Siemens Healthineers Recent Developments and Future Plans Figure 32. Trivitron Healthcare Recent Developments and Future Plans Figure 33. F. Hoffmann-La Roche Ltd Recent Developments and Future Plans Figure 34. Abbott Recent Developments and Future Plans Figure 35. Quest Diagnostics, Inc Recent Developments and Future Plans Figure 36. BD & Company Recent Developments and Future Plans Figure 37. Chembio Diagnostics Inc Recent Developments and Future Plans Figure 38. Trinity Biotech Recent Developments and Future Plans Figure 39. Cardinal Health Recent Developments and Future Plans Figure 40. Bio-Rad Labs Inc. Recent Developments and Future Plans Figure 41. bioMA(C)rieux SA Recent Developments and Future Plans Figure 42. Thermo Fisher Scientific Inc Recent Developments and Future Plans Figure 43. Sight Diagnostics Ltd. Recent Developments and Future Plans Figure 44. Gene POC Recent Developments and Future Plans Figure 45. Ortho-Clinical Diagnostics Recent Developments and Future Plans Figure 46. OJ-Bio Ltd. Recent Developments and Future Plans Figure 48. Global Point of Care Infectious Disease Revenue Share by Players in 2020 Figure 49. Point of Care Infectious Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3) Figure 50. Global Top 3 Players Point of Care Infectious Disease Revenue Market Share in 2020 Figure 51. Global Top 10 Players Point of Care Infectious Disease Revenue Market Share in 2020 Figure 52. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021) Figure 53. Global Point of Care Infectious Disease Revenue Share by Type in 2020 Figure 54. Global Point of Care Infectious Disease Market Share Forecast by Type (2021-2026) Figure 55. Global Point of Care Infectious Disease Revenue Share by Application in 2020 Figure 56. Global Point of Care Infectious Disease Market Share Forecast by Application (2021-2026) Figure 57. North America Point of Care Infectious Disease Sales Market Share by Type (2016-2026) Figure 58. North America Point of Care Infectious Disease Sales Market Share by Application (2016-2026) Figure 59. North America Point of Care Infectious Disease Revenue Market Share by Country (2016-2026) Figure 60. United States Point of Care Infectious Disease Revenue and Growth Rate (2016-2026) & (USD Million) Figure 61. Canada Point of Care Infectious Disease Revenue and Growth Rate (2016-2026) & (USD Million) Figure 62. Mexico Point of Care Infectious Disease Revenue and Growth Rate (2016-2026) & (USD Million) Figure 63. Europe Point of Care Infectious Disease Sales Market Share by Type (2016-2026) Figure 64. Europe Point of Care Infectious Disease Sales Market Share by Application (2016-2026) Figure 65. Europe Point of Care Infectious Disease Revenue Market Share by Country (2016-2026) Figure 66. Germany Point of Care Infectious Disease Revenue and Growth Rate (2016-2026) & (USD Million) Figure 67. France Point of Care Infectious Disease Revenue and Growth Rate (2016-2026) & (USD Million) Figure 68. United Kingdom Point of Care Infectious Disease Revenue and Growth Rate (2016-2026) & (USD Million) Figure 69. Russia Point of Care Infectious Disease Revenue and Growth Rate (2016-2026) & (USD Million) Figure 70. Italy Point of Care Infectious Disease Revenue and Growth Rate (2016-2026) & (USD Million) Figure 71. Asia-Pacific Point of Care Infectious Disease Sales Market Share by Type (2016-2026) Figure 72. Asia-Pacific Point of Care Infectious Disease Sales Market Share by Application (2016-2026) Figure 73. Asia-Pacific Point of Care Infectious Disease Revenue Market Share by Region (2016-2026) Figure 74. China Point of Care Infectious Disease Revenue and Growth Rate (2016-2026) & (USD Million) Figure 75. Japan Point of Care Infectious Disease Revenue and Growth Rate (2016-2026) & (USD Million) Figure 76. South Korea Point of Care Infectious Disease Revenue and Growth Rate (2016-2026) & (USD Million) Figure 77. India Point of Care Infectious Disease Revenue and Growth Rate (2016-2026) & (USD Million) Figure 78. Southeast Asia Point of Care Infectious Disease Revenue and Growth Rate (2016-2026) & (USD Million) Figure 79. Australia Point of Care Infectious Disease Revenue and Growth Rate (2016-2026) & (USD Million) Figure 80. South America Point of Care Infectious Disease Sales Market Share by Type (2016-2026) Figure 81. South America Point of Care Infectious Disease Sales Market Share by Application (2016-2026) Figure 82. South America Point of Care Infectious Disease Revenue Market Share by Country (2016-2026) Figure 83. Brazil Point of Care Infectious Disease Revenue and Growth Rate (2016-2026) & (USD Million) Figure 84. Argentina Point of Care Infectious Disease Revenue and Growth Rate (2016-2026) & (USD Million) Figure 85. Middle East and Africa Point of Care Infectious Disease Sales Market Share by Type (2016-2026) Figure 86. Middle East and Africa Point of Care Infectious Disease Sales Market Share by Application (2016-2026) Figure 87. Middle East and Africa Point of Care Infectious Disease Revenue Market Share by Country (2016-2026) Figure 88. Turkey Point of Care Infectious Disease Revenue and Growth Rate (2016-2026) & (USD Million) Figure 89. Saudi Arabia Point of Care Infectious Disease Revenue and Growth Rate (2016-2026) & (USD Million) Figure 90. UAE Point of Care Infectious Disease Revenue and Growth Rate (2016-2026) & (USD Million) Figure 91. Methodology Figure 92. Research Process and Data Source

Qualitative Analysis covers:

  • Industry Status and Trends
  • Manufacturer/Company profiles, manufacturing base distribution, sales areas, product introduction, main business, market position and their competitors.
  • Product Development, Technology, Price, Cost, Manufacturing Process and Trends
  • Market segment by regions, types, applications and forecast
  • Market opportunities, potential, government policies and influence factors.
     

Quantitative Analysis covers:

  • Market size (value, sales/output, historical data and forecasts)
  • Sales/output/capacity, revenue, price, gross margin, market share, for top players. Through interviewing each manufacturers,  distributors, traders, dealers and buyers etc.
  • Cost structure, proportion, price trend, gross margin and trend, status and trend, for 10 years
  • Market size by types, regions, applications for 10 years
  • Market forecast based on the potential demand from downstream clients/buyers, government, influence factors and the total economic indication, maybe occur in following years.
     

Data Sources:

Methodology

 

Publisher: GlobalInfoResearch
Chat with us